Content area

|
|

Vulvær intraepitelial neoplasi

Forfatter(e)
Signe Østergård1, Christina Steen Vorbeck2 & Mette Meinert3 1) Kirurgisk Afdeling, Regionshospitalet Randers 2) Onkologisk Afdeling, Rigshospitalet 3) Kvindesygdomme og Fødsler, Aarhus Universitetshospital Ugeskr Læger 2018;180:V12170931
Reference: 
Ugeskr Læger 2018;180:V12170931
Sidetal: 
2-5
Vulvar intraepithelial neoplasia
Vulvar intraepithelial neoplasia (VIN) is a rare but premalig­nant condition. VIN has two aetiological pathways: a human papillomavirus (HPV)-dependent pathway, which is a vulvar high-grade squamous intraepithelial lesion (HSIL), and an HPV-independent pathway, called differentiated VIN (d-VIN), associated with lichen sclerosus. d-VIN is more aggressive than vulvar HSIL. In case of symptoms, a biopsy should be performed. The recurrence risk is high: 25-50% regardless of treatment type. We recommend treatment with imiquimod as first choice to avoid mutilating surgery. Particular attention must be payed to immunosuppressed patients with VIN. HPV-vaccine can be discussed with patients with vulvar HSIL.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Jens Enné Sletgaard | 20/09
3 kommentarer
af Alice Kunkel | 17/09
7 kommentarer
af Jørn Rosborg | 17/09
1 Kommentar
af Peter Christian Gøtzsche | 17/09
1 Kommentar
af Jens Ole Mathiesen | 16/09
3 kommentarer
af Annette Randløv | 16/09
2 kommentarer
af Jens Ole Mathiesen | 15/09
4 kommentarer
af Jens Ole Mathiesen | 14/09
4 kommentarer
af Steffen Thirstrup | 11/09
4 kommentarer